News & Updates

Chronification and mixed pain: Pragmatic best-practice approach to novel chronic pain concepts

The Viatris Pain Summit 2022 Symposium Highlight

Emerging organ protective therapies in T2DM

The goals of diabetes care are to prevent complications and optimize quality of life. Current developments in diabetes management have shifted focus from just glycemic control to the inclusion of organ protection. In the Boehringer Ingelheim-sponsored webinar entitled “Deep dive in EMPA-KIDNEY” held last December 9, 2022, Dr Nestor Eric Laplano, Consultant, Skyline Hospital and Medical Center and Grace General Hospital, SJDM Bulacan; and Dr David Cherney, Active Consultant, University Health Network and Mount Sinai Hospital Toronto Canada, revisited treatment strategies and discussed the EMPA-KIDNEY trial and its implications in organ protective therapies for type 2 diabetes.

[ Dr David Cherney ]
Dr David Cherney
Speaker

[ Dr Nestor Eric Laplano ]
Dr Nestor Eric Laplano
Moderator

Put Life Back in Your Patients’ Hands: Winning the fight Against Peripheral Neuropathy in Diabetic Patients

Dear Doctor,  

In celebration of World Diabetes Day, P&G Health Philippines, in partnership with the Philippine Association of Family Physicians (PAFP), Philippine Society of Endocrinology, Diabetes and Metabolism (PSEDM), and the Cavite Medical Society (CMS) recently held the “Put Life Back in Your Patients’ Hands: Winning the Fight against Neuropathy in Diabetes” physical-digital event for healthcare professionals, we made sure you don’t miss the updates and innovations in nerve care that were discussed. 

Catch the highlights of the “phygital” event here.  

Diabetes Mellitus DMT2 GLP1-RA Dulaglutide

Zvolution - Making Healthcare More Accessible

Staying true to its long history of committed partnership with healthcare professionals on Continuing Medical Education (CME) and product innovation, ZP Therapeutics made a grand return to face-to-face CME events in celebration of ZP Therapeutics’ illustrious 100-year history as a leading healthcare industry partner. The ZPT Exposition of Experts in Improving Patient Outcomes 2022, themed “Zvolution -Making Healthcare More Accessible”, was held at the Conrad Hotel in Pasay City last 23–24 September 2022 and featured a panel of top-notch speakers whose talks covered a broad range of topics from digital health solutions to Gastroenterology, bone health, immunity as well as critical care in diabetes, and Cardiology. 

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

The selective, oral sodium–glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the risk of cardiovascular (CV) death or worsening heart failure (HF) in patients with HF and mildly reduced or preserved ejection fraction (HFmrEF or HFpEF) in the phase III DELIVER* trial, touted as the largest and most inclusive thus far in this patient group.

Neurology, Sleep Medicine, OB and Gyne, Endocrinology, ENT

After the success of our previous online scientific seminar entitled Riding the Wave, Procter & Gamble Health in alliance with the Philippine Academy of Family Physicians and the Philippine Pharmacists Association were excited to present the next installment in the series, Breaking the Wave.

Held virtually from April 28 – 29, 2022, this edition tackled key factors in the transition from pandemic to recovery including neuropathy, nutritional supplements, and immunity.

The speakers at this event were Prof. Rayaz Malik, Professor of Medicine at Weill Cornell Medical College (Qatar); Dr. Arabinda Mukherjee, Professor of Neurology at the Vivekananda Institute of Medical Sciences (Calcutta); Dr. Aimee Andag-Silva, Chief of the Section of Endocrinology at the De La Salle University Medical Center College of Medicine; Dr. Maria Carmen Quevedo, Associate Professor of the Department of Obstetrics and Gynecology at Far Eastern University Nicanor Reyes Memorial Medical Center; Dr. Antonio H. Chua, Pediatric Otorhinolaryngologist at St. Luke’s Medical Center – Global City; and Dr. Keith Romeo Aguilera, Center Head of the Comprehensive Sleep Disorders Center at St. Luke’s Medical Center – Global City. The event’s moderators were Dr. Lynne Marcia Bautista, a fellow of the Philippine Association of Family Physicians; Mr. Mark Ryan Langit, professor at the Saint Louis University College of Pharmacy; and Dr. Digna Almeida, Senior Medical & Technical Affairs Manager of P&G Health. 

Product Highlight - HEALTHY-KIDZ

β-glucan, Echinacea purpurea, oat extr, vit C (Na ascorbate), Zn gluconate oral liqd

Product Highlight - MEPRESONE

Methylprednisolone 4 mg & 16 mg tab, 40 mg powd for inj

Product Highlight - SOLIQUA

Insulin glargine + Lixisenatide 100 u/mL + 50 mcg/mL solution for injection (3 mL pre-filled pen); 100 u/mL + 33 mcg/mL solution for injection (3 mL pre-filled pen)